Skip to main content
. 2009 Jun;87(2):417–442. doi: 10.1111/j.1468-0009.2009.00563.x

Figure 1.

Figure 1

Trends in the Proportion of All Surgically Treated Patients Who Underwent Contralateral Prophylactic Mastectomy (CPM-A) by Cancer Stage at Diagnosis

Note: The Cochran-Armitage tests for trend for CPM-A rates overall and by stage were significant (p < .001).

Source: T.M. Tuttle, E.B. Habermann, E.H. Grund, T.J. Morris, and B.A. Virnig, Increasing Use of Contralateral Prophylactic Mastectomy for Breast Cancer Patients: A Trend toward More Aggressive Surgical Treatment, Journal of Clinical Oncology (published online, October 22, 2007). Reproduced with permission of the Journal of Clinical Oncology.